These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 791345)
1. Differential expression of cell surface binding sites for cholera toxin in acute and chronic leukaemias. Revesz T; Greaves MF; Capellaro D; Murray RK Br J Haematol; 1976 Dec; 34(4):623-30. PubMed ID: 791345 [TBL] [Abstract][Full Text] [Related]
2. Analysis of human leukaemic cells using cell surface binding probes and the fluorescence activated cell sorter. Greaves M; Capellaro D; Brown G; Revesz T; Janossy G Hamatol Bluttransfus; 1976; 19():243-60. PubMed ID: 795743 [TBL] [Abstract][Full Text] [Related]
3. Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. Holmgren J; Lindholm L; Lönnroth I J Exp Med; 1974 Apr; 139(4):801-19. PubMed ID: 4361243 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin. Katz HR; Levine JS; Austen KF J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431 [TBL] [Abstract][Full Text] [Related]
12. Destruction of cholera toxin receptor on HeLa cell membrane using microbial endoglycoceramidase. Yamamoto K; Nagano T; Kumagai H; Okamoto Y; Otani S Arch Biochem Biophys; 1996 Apr; 328(1):51-6. PubMed ID: 8638937 [TBL] [Abstract][Full Text] [Related]
13. Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Brown G; Greaves MF; Lister TA; Rapson N; Papamichael M Lancet; 1974 Sep; 2(7883):753-5. PubMed ID: 4143016 [No Abstract] [Full Text] [Related]
14. Immunotherapy of human leukemia with neuraminidase-modified cells. Holland JF; Bekesi JG Med Clin North Am; 1976 May; 60(3):539-49. PubMed ID: 1063908 [No Abstract] [Full Text] [Related]
15. Membrane expression of Thy-1,2 and GM1 ganglioside on differentiating T lymphocytes. Milewicz C; Miller HC; Esselman WJ J Immunol; 1976 Nov; 117(5 Pt.2):1774-80. PubMed ID: 1086862 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of surface monosialoganglioside GM1 in various hemic cell lines of normal human bone marrow. A quantitative immunocytochemical study using the cholera toxin-gold-labeled anti-cholera toxin procedure. Ackerman GA; Wolken KW; Gelder FB J Histochem Cytochem; 1980 Dec; 28(12):1334-42. PubMed ID: 7014713 [TBL] [Abstract][Full Text] [Related]
17. Unmasking of actual and potential receptor sites for cholera toxin in intestinal mucosal homogenates. Gascoyne N; van Heyningen WE J Infect Dis; 1979 Feb; 139(2):235-6. PubMed ID: 438537 [TBL] [Abstract][Full Text] [Related]
18. Effects of cholera exotoxin on Fc receptor activity of lymphoid cells and mononuclear phagocytes. Zuckerman SH; Douglas SD Immunology; 1977 Mar; 32(3):247-53. PubMed ID: 191391 [TBL] [Abstract][Full Text] [Related]
19. On the cellular localization and distribution of the ganglioside GM1 in the rat brain as revealed by immunofluorescence histochemistry of cholera toxin binding sites. Fuxe K; Tinner B; Janson AM; Cintra A; Staines W; Agnati LF Acta Physiol Scand; 1989 Dec; 137(4):551-2. PubMed ID: 2690577 [No Abstract] [Full Text] [Related]
20. Interaction of cholera toxin and ganglioside G(M1). Svennerholm L Adv Exp Med Biol; 1976; 71():191-204. PubMed ID: 937147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]